Sarah Mele

Sarah Mele

Auto-generated profile, based on publicly available information

Sarah Mele

Department of Biochemistry and Chemistry, and La Trobe Institute for Molecular Sciences, La Trobe University, Bundoora, Victoria 3086, Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2024 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
SMSarah Mele
Sarah Mele
Felipe MartelliFelipe Martelli
Felipe Martelli
CBChristopher Barlow
Christopher Barlow
GJGrace Jefferies
Grace Jefferies
SDSebastian Dworkin
Sebastian Dworkin
TJTravis Johnson
Travis Johnson

30 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
Felipe MartelliFelipe Martelli
Felipe Martelli
AQAnnelise Quig
Annelise Quig
SMSarah Mele
Sarah Mele
JLJiayi Lin
Jiayi Lin
TFTahlia L. Fulton
Tahlia L. Fulton
MPMatthew Piper
Matthew Piper
Drosophila melanogaster is unique among animal models because it has a fully defined synthetic diet available to study nutrient-gene interactions. However, use of this diet is limited to adult studies due to impaired larval development and survival. Here, we provide an adjusted formula that improves larval growth, development rate, and rescues survival. We demonstrate its use for exploring pre-adult diet compositions of therapeutic potential in a model of an inherited metabolic disorder.

1 February 2026 in Disease Models & Mechanisms
Verified
Journal Article
Open access
SMSarah Mele
Sarah Mele
JMJoshua Millward
Joshua Millward
LNLong Nguyen
Long Nguyen
NRNatasha Ruth
Natasha Ruth
JGJemma Gasperoni
Jemma Gasperoni
TJTravis Johnson
Travis Johnson
Quantitative behavioural analysis is a powerful approach for linking genotype to phenotype, but many existing tools require specialised hardware, extensive preprocessing or coding expertise. We present Segment Anything Model for Behavioural Analysis (SAMBA), an open-access, Google Colab-based pipeline that harnesses the Segment Anything Model 2 (SAM2) for accurate, semi-automated tracking without thresholding or background subtraction. With minimal user input, SAMBA extracts movement parameters, detects behavioural states and supports batch processing. Validating SAMBA in three Drosophila melanogaster models of human neurological disease revealed impaired locomotion, reduced speed and altered decision-making. We further demonstrated adaptability to adult Drosophila and larval zebrafish, underscoring its cross-species utility. By combining foundation-model segmentation with an accessible interface, SAMBA lowers technical barriers to analysing motor pattern defects and is readily extendable to diverse model organisms, life stages and experimental paradigms. This flexibility positions SAMBA as a valuable platform for accelerating disease mechanism studies, genetic screens and preclinical testing.

25 August 2025 in bioRxiv
Verified
Preprint
Open access
SMSarah Mele
Sarah Mele
LNLong Nguyen
Long Nguyen
JMJoshua Millward
Joshua Millward
JGJemma Gasperoni
Jemma Gasperoni
SDSebastian Dworkin
Sebastian Dworkin
TJTravis Johnson
Travis Johnson
Quantitative behavioural analysis is a powerful approach for linking genotype to phenotype, but many existing tools require specialised hardware, extensive preprocessing, or coding expertise. We present SAMBA (Segment Anything Model for Behavioural Analysis), an open-access, Google Colab-based pipeline that harnesses the Segment Anything Model 2 (SAM2) for accurate, semi-automated tracking without thresholding or background subtraction. With minimal user input, SAMBA extracts movement parameters, detects behavioural states, and supports batch processing. Validating SAMBA in a Drosophila melanogaster model of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency revealed impaired locomotion, reduced speed, and altered decision-making, highlighting its ability to capture nuanced phenotypes in neurometabolic disease. We further demonstrate adaptability to adult Drosophila and larval zebrafish, underscoring its cross-species utility. By combining foundation-model segmentation with an accessible interface, SAMBA lowers technical barriers to high-throughput behavioural phenotyping and is readily extendable to diverse model organisms, life stages, and experimental paradigms. This flexibility positions SAMBA as a valuable platform for accelerating disease mechanism studies, genetic screens, and preclinical testing. SUMMARY STATEMENT: We present an easy-to-use, open-access tool designed for Drosophila larval movement analysis, and readily customised for other applications, enabling rapid, scalable assessment of organism behaviour without specialised equipment or coding expertise.

3 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZNZoriana Novosiadla
Zoriana Novosiadla
SMSarah Mele
Sarah Mele
EKEmily Kerton
Emily Kerton
JCJohn Christodoulou
John Christodoulou
SDSebastian Dworkin
Sebastian Dworkin
TJTravis Johnson
Travis Johnson
Nutrient-gene interactions shape metabolic disease phenotypes, but systematic testing is limited by the effort required to produce defined diets. We developed a flexible protocol that assembles precisely defined synthetic diets for Drosophila melanogaster from individual stock solutions. Using this approach, we generated a rational array of 51 single-nutrient-varied diets and demonstrated that flexible and standard preparation methods produce comparable developmental timing, survival, adult body weight, and starvation resistance in wildtype flies. Applying the dietary array to a Drosophila model of isolated sulfite oxidase deficiency, a severe condition caused by impaired sulfur amino acid catabolism, revealed nutrient-specific effects on pupal survival and pupariation timing, including rescue by cysteine depletion and other amino acid modified diets. This platform provides a scalable in vivo framework for mapping genotype-specific nutritional responses across Drosophila disease models. Key points: Developed a flexible platform for assembling precisely defined synthetic diets in Drosophila . Generated a rational 51-diet array, enabling scalable nutrigenomic screening. Flexible and standard diet preparations yielded matching developmental and adult fitness outcomes. Dietary array screening in a sulfite oxidase deficiency model recapitulated cysteine sensitivity and identified novel nutrient modifiers.

17 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSarah Mele
Sarah Mele
Felipe MartelliFelipe Martelli
Felipe Martelli
CBChristopher Barlow
Christopher Barlow
GJGrace Jefferies
Grace Jefferies
SDSebastian Dworkin
Sebastian Dworkin
TJTravis Johnson
Travis Johnson
Summary: Short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) is a rare genetic disorder caused by biallelic pathogenic variants in the ECHS1 gene. ECHS1D is characterised by severe neurological and physical impairment that often leads to childhood mortality. Therapies such as protein and single nutrient-restricted diets show poor efficacy, whereas development of new treatments is hindered by the low prevalence of the disorder and a lack of model systems for treatment testing. Here we report on the establishment of a Drosophila model of ECHS1D. Flies carrying mutations in Echs1 (CG6543) were characterised for their physical and metabolic phenotypes, and dietary intervention to improve fly model health was explored. The Echs1 null larvae recapitulated human ECHS1D phenotypes including elevated biomarkers (S-(2-carboxypropyl)cysteamine and 2,3-dihydroxy-2-methylbutyric acid), poor motor behaviour and early mortality, and could be rescued by expression of a human ECHS1 transgene. We observed that both restriction of valine in isolation, or all branched-chain amino acids (BCAAs - leucine, isoleucine, and valine) together, extended larval survival, supporting the idea that reducing BCAA pathway catabolic flux is beneficial in this disorder. Further, metabolic profiling revealed substantial changes to carbohydrate metabolism, suggesting that Echs1 loss causes widespread metabolic dysregulation beyond valine metabolism. The similarities between Drosophila and human ECHS1D suggest that the fly model is a valuable animal system in which to explore mechanisms of pathogenesis and novel treatment options for this disorder.